Marinus Pharmaceuticals reported $-0.94 in EPS Earnings Per Share for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acadia Pharmaceuticals ACAD:US USD 0 0
ALKERMES ALKS:US USD 0.02 0.04
Amgen AMGN:US USD 4.7 0.05
Aptinyx Inc APTX:US USD -0.23 0.03
Biogen BIIB:US USD 4.77 0.48
Eisai 4523:JP JPY 12.44 81.37
Enanta Pharmaceuticals ENTA:US USD -1.53 0.1
Esperion Therapeutics ESPR:US USD -0.81 0.24
Gilead Sciences GILD:US USD 1.9 0.32
Intercept Pharmaceuticals ICPT:US USD 7.8 8.48
Intra Cellular Therapies ITCI:US USD -0.57 0.35
Marinus Pharmaceuticals MRNS:US USD -0.94 0.12
Minerva Neurosciences NERV:US USD -1.29 0.34
Neurocrine Biosciences NBIX:US USD 0.69 0.87
Ptc Therapeutics PTCT:US USD -1.53 0.6
Regeneron Pharmaceuticals REGN:US USD 11.14 1.37
Sarepta Therapeutics SRPT:US USD -2.94 0.29
Supernus Pharmaceuticals SUPN:US USD 0.03 0.11
UCB UCB:BB EUR 2.05 0.47
Vertex Pharmaceuticals VRTX:US USD 4.01 0.41
YTE INCY:US USD 0.6 0.41